Hydromorphon Hcl

Hydromorphone Hydrochloride, the active ingredient in Hydromorphon Hcl, is an opioid analgesic presented as an oral dosage form for systemic use. It is indicated for the management of moderate to severe pain in adult patients when alternative therapies are inadequate.

GNH USA supplies Hydromorphon Hcl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Hydromorphone Hydrochloride is an opioid analgesic used to treat pain conditions that involve the central nervous system. - Moderate to severe acute pain: provides rapid and potent analgesia for postoperative or trauma‑related pain. - Cancer‑related pain: reduces intense nociceptive and neuropathic pain associated with malignancy. - Chronic non‑cancer pain: alleviates persistent severe pain when other treatments have failed. - Post‑surgical pain: controls acute pain following major surgical procedures.

Hydromorphone Hydrochloride may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Constipation: reduced bowel motility. - Drowsiness: increased sleepiness. - Dizziness: sensation of light‑headedness. - Dry mouth: reduced salivation. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Seizures: occasional convulsive episodes. - Allergic reactions: rash, itching, or anaphylaxis. - Adrenal insufficiency: impaired cortisol response. - Dependence or addiction: risk of misuse with prolonged use.

When prescribing or dispensing Hydromorphone Hydrochloride, clinicians should consider several safety measures. - Assess respiratory function: monitor for depression, especially in opioid‑naïve patients. - Evaluate renal and hepatic function: dose may need adjustment in impairment. - Avoid use with CNS depressants: increased risk of sedation and respiratory compromise. - Pregnancy and lactation: use only if benefit outweighs potential fetal or infant risk. - Risk of dependence: limit duration and monitor for signs of misuse. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Hydromorphone Hydrochloride can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Concomitant CNS depressants: may cause profound sedation and respiratory depression. - Monoamine oxidase inhibitors (MAOIs): risk of severe opioid toxicity. - Potent CYP3A4 inhibitors (e.g., ketoconazole): increase plasma concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): may reduce analgesic efficacy. - Serotonergic agents (e.g., SSRIs): potential for serotonin syndrome. - Diuretics: may enhance hypotensive effects when combined.